Literature DB >> 23640417

Screening for genomic rearrangements at BRCA1 locus in Iranian women with breast cancer using multiplex ligation-dependent probe amplification.

Vahid R Yassaee1, Babak Emamalizadeh, Mir Davood Omrani.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23640417     DOI： 10.1007/s12041-013-0223-5

Source DB:  PubMed          Journal:  J Genet        ISSN： 0022-1333            Impact factor:   1.166


× No keyword cloud information.
  22 in total

1.  Exclusion of large deletions and other rearrangements in BRCA1 and BRCA2 in Finnish breast and ovarian cancer families.

Authors:  J Lahti-Domenici; K Rapakko; K Pääkkönen; M Allinen; H Nevanlinna; M Kujala; P Huusko; R Winqvist
Journal:  Cancer Genet Cytogenet       Date:  2001-09

2.  Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification.

Authors:  Jan P Schouten; Cathal J McElgunn; Raymond Waaijer; Danny Zwijnenburg; Filip Diepvens; Gerard Pals
Journal:  Nucleic Acids Res       Date:  2002-06-15       Impact factor: 16.971

3.  BRCA1 physically associates with p53 and stimulates its transcriptional activity.

Authors:  H Zhang; K Somasundaram; Y Peng; H Tian; H Zhang; D Bi; B L Weber; W S El-Deiry
Journal:  Oncogene       Date:  1998-04-02       Impact factor: 9.867

Review 4.  BRCA1 and BRCA2 and the genetics of breast and ovarian cancer.

Authors:  P L Welcsh; M C King
Journal:  Hum Mol Genet       Date:  2001-04       Impact factor: 6.150

5.  Screening for large rearrangements of the BRCA1 gene in German breast or ovarian cancer families using semi-quantitative multiplex PCR method.

Authors:  Wera Hofmann; Heike Görgens; Anika John; Denise Horn; Christine Hüttner; Norbert Arnold; Siegfried Scherneck; Hans K Schackert
Journal:  Hum Mutat       Date:  2003-07       Impact factor: 4.878

6.  Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer.

Authors:  Tom Walsh; Silvia Casadei; Kathryn Hale Coats; Elizabeth Swisher; Sunday M Stray; Jake Higgins; Kevin C Roach; Jessica Mandell; Ming K Lee; Sona Ciernikova; Lenka Foretova; Pavel Soucek; Mary-Claire King
Journal:  JAMA       Date:  2006-03-22       Impact factor: 56.272

7.  Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles.

Authors:  Sheila Seal; Deborah Thompson; Anthony Renwick; Anna Elliott; Patrick Kelly; Rita Barfoot; Tasnim Chagtai; Hiran Jayatilake; Munaza Ahmed; Katarina Spanova; Bernard North; Lesley McGuffog; D Gareth Evans; Diana Eccles; Douglas F Easton; Michael R Stratton; Nazneen Rahman
Journal:  Nat Genet       Date:  2006-10-08       Impact factor: 38.330

8.  PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene.

Authors:  Nazneen Rahman; Sheila Seal; Deborah Thompson; Patrick Kelly; Anthony Renwick; Anna Elliott; Sarah Reid; Katarina Spanova; Rita Barfoot; Tasnim Chagtai; Hiran Jayatilake; Lesley McGuffog; Sandra Hanks; D Gareth Evans; Diana Eccles; Douglas F Easton; Michael R Stratton
Journal:  Nat Genet       Date:  2006-12-31       Impact factor: 38.330

9.  Novel mutations in the BRCA1 and BRCA2 genes in Iranian women with early-onset breast cancer.

Authors:  Vahid R Yassaee; Sirous Zeinali; Iraj Harirchi; Soghra Jarvandi; Mohammad A Mohagheghi; David P Hornby; Ann Dalton
Journal:  Breast Cancer Res       Date:  2002-04-16       Impact factor: 6.466

10.  Dosage analysis of cancer predisposition genes by multiplex ligation-dependent probe amplification.

Authors:  D J Bunyan; D M Eccles; J Sillibourne; E Wilkins; N Simon Thomas; J Shea-Simonds; P J Duncan; C E Curtis; D O Robinson; J F Harvey; N C P Cross
Journal:  Br J Cancer       Date:  2004-09-13       Impact factor: 7.640
View more
  1 in total

1.  Male Breast Cancer: Results of the Application of Multigene Panel Testing to an Italian Cohort of Patients.

Authors:  Gianluca Tedaldi; Michela Tebaldi; Valentina Zampiga; Ilaria Cangini; Francesca Pirini; Elisa Ferracci; Rita Danesi; Valentina Arcangeli; Mila Ravegnani; Giovanni Martinelli; Fabio Falcini; Paola Ulivi; Daniele Calistri
Journal:  Diagnostics (Basel)       Date:  2020-04-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.